This is an application for continued support for years 41-45 of a postdoctoral training program in medical genetics based in the Department of Molecular and Human Genetics (DMHG) at Baylor College of Medicine (BCM). The DMHG is a bridging department with major clinical activities and strong programs in basic, translational, and clinical research. It uniquely integrates many of the activities that are traditionally found dispersed through many academic departments and centers at most US academic institutions into a single department at BCM. The emphasis of this postdoctoral program is on medical and human genetics and on molecular approaches. There are 90 training faculty, 69 with primary and 21 with secondary appointments in the DMHG (up from 79 in the last renewal submission in 2012). As part of a transition plan in program leadership in 2012, Dr. Lee, took over as the PI of this training grant in renewing it for the current funding cycle (years 36-40) from Dr. Arthur L. Beaudet. In continuation of this transition, Dr. Lee was appointed Chairman of DMHG in Dec 2014 after an international search. An ambitious strategic plan has been implemented over the past two years that has further enhanced the training environment including new faculty recruitment, development of new clinical training tracks, formation of a diagnostic laboratory joint venture, and development of a virtual platform to facilitate patient engagement in clinical care, education, and research. However, the core of the Department mission remains research spanning all areas of human and model organism genetics. Trainees derive mainly from ACGME and ABMGG approved residency and fellowship programs. The primary focus of the program is to attract highly qualified MD and MD/PhD trainees who seek an intensive and substantial research experience. In the past four years of funding, 87.5% of slots were assigned to MD or MD/PhD trainees. Powerful drivers of training include faculty integration at the Department, Center, and NIH program levels and leading clinical implementation of innovative technologies including array comparative genomic hybridization, whole exome sequencing, metabolomics, and cell free noninvasive prenatal gene sequencing in this application. Our stellar alumni who now populate our and many other medical genetics programs support the success of this central tenet. Major strengths of the training environment include a large clinical genetics component; large, comprehensive, and sophisticated diagnostic laboratories; 170,000 square feet of space for the department activities; strong institutional commitment; a genetic graduate student program with relevant course work; ACGME and ABMGG-certified training programs; high national ranking of NIH funding for genetics departments (1st); NIH Large Scale Sequencing Center; NIH Intellectual and Developmental Disability Research Center; NIH Center for Mendelian Genomics; NIH Undiagnosed Diseases Network (UDN) Clinical Site (CS), Sequencing Core (SC), and Model Organism Screening Center (MOSC); and NIH Knockout Mouse Phenotyping Program (KOMP3).
This is a training grant that supports primarily MD and MD/PhD trainees enrolled in human and medical genetics training. It has a long tradition of training current and future leaders in medical genetics research.
|Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287|
|Nagamani, Sandesh C S; Agarwal, Umang; Tam, Allison et al. (2018) A randomized trial to study the comparative efficacy of phenylbutyrate and benzoate on nitrogen excretion and ureagenesis in healthy volunteers. Genet Med 20:708-716|
|Wiszniewski, Wojciech; Gawlinski, Pawel; Gambin, Tomasz et al. (2018) Comprehensive genomic analysis of patients with disorders of cerebral cortical development. Eur J Hum Genet 26:1121-1131|
|Jain, Mahim; Tam, Allison; Shapiro, Jay R et al. (2018) Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study. Genet Med :|
|Tam, Allison; Chen, Shan; Schauer, Evan et al. (2018) A multicenter study to evaluate pulmonary function in osteogenesis imperfecta. Clin Genet 94:502-511|
|Tam, Allison; Sliepka, Joseph M; Bellur, Sunil et al. (2018) Neuroimaging findings of extensive sphenoethmoidal dysplasia in NF1. Clin Imaging 51:160-163|
|Marom, Ronit; Jain, Mahim; Burrage, Lindsay C et al. (2017) Heterozygous variants in ACTL6A, encoding a component of the BAF complex, are associated with intellectual disability. Hum Mutat 38:1365-1371|
|Machol, Keren; Jain, Mahim; Almannai, Mohammed et al. (2017) Corner fracture type spondylometaphyseal dysplasia: Overlap with type II collagenopathies. Am J Med Genet A 173:733-739|
|Falah, Nadia; Posey, Jennifer E; Thorson, Willa et al. (2017) 22q11.2q13 duplication including SOX10 causes sex-reversal and peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome, and Hirschsprung disease. Am J Med Genet A 173:1066-1070|
|Santiago-Sim, Teresa; Burrage, Lindsay C; Ebstein, Frédéric et al. (2017) Biallelic Variants in OTUD6B Cause an Intellectual Disability Syndrome Associated with Seizures and Dysmorphic Features. Am J Hum Genet 100:676-688|
Showing the most recent 10 out of 127 publications